Impact of commonly used medications on the detection of clinically significant prostate cancer in the targeted biopsy era
{{output}}
Objectives: To compare prostate cancer rates in magnetic resonance imaging (MRI)-detected lesions for patients who are chronically taking beta-blockers, nonsteroidal anti-inflammatory drugs (NSAIDs), or immunosuppressors. ... ...
